Advisory Advocates’s Lam Research LRCX Stock Holding History

Advisory Advocates’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$406K	Buy	+937	New	+$284K	0.35%	107

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Advisory Advocates's LRCX Position: Q2 2026 in Review

Advisory Advocates opened a new position in Lam Research (LRCX) in Q2 2026: 937 shares worth $406K. The stake represents 0.35% of the portfolio and ranks #107 among its holdings.

2,991 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Advisory Advocates held 937 shares of Lam Research worth $406K as of Q2 2026.
Lam Research was a new Advisory Advocates position in Q2 2026.
Lam Research made up 0.35% of Advisory Advocates's portfolio in Q2 2026, its #107 holding.
2,991 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Advisory Advocates's 13F filing for Q2 2026, filed 10 Aug 2026.